BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 17130631)

  • 21. "The Big WHY": Philip Morris's failed search for corporate social value.
    McDaniel PA; Malone RE
    Am J Public Health; 2012 Oct; 102(10):1942-50. PubMed ID: 22897536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The tobacco industry and underage youth smoking: tobacco industry documents from the Minnesota litigation.
    Perry CL
    Arch Pediatr Adolesc Med; 1999 Sep; 153(9):935-41. PubMed ID: 10482208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Challenging the epidemiologic evidence on passive smoking: tactics of tobacco industry expert witnesses.
    Francis JA; Shea AK; Samet JM
    Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv68-76. PubMed ID: 17130626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Shared vision, shared vulnerability: A content analysis of corporate social responsibility information on tobacco industry websites.
    McDaniel PA; Cadman B; Malone RE
    Prev Med; 2016 Aug; 89():337-344. PubMed ID: 27261411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beliefs about tobacco industry (mal)practices and youth smoking behaviour: insight for future tobacco control campaigns (Canada).
    Leatherdale ST; Sparks R; Kirsh VA
    Cancer Causes Control; 2006 Jun; 17(5):705-11. PubMed ID: 16633918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mind your "smoking manners": the tobacco industry tactics to normalize smoking in Japan.
    Kashiwabara M; Armada F
    Kobe J Med Sci; 2013 Nov; 59(4):E132-40. PubMed ID: 24598274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Corporate social responsibility and access to policy élites: an analysis of tobacco industry documents.
    Fooks GJ; Gilmore AB; Smith KE; Collin J; Holden C; Lee K
    PLoS Med; 2011 Aug; 8(8):e1001076. PubMed ID: 21886485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "The world's most hostile environment": how the tobacco industry circumvented Singapore's advertising ban.
    Assunta M; Chapman S
    Tob Control; 2004 Dec; 13 Suppl 2(Suppl 2):ii51-7. PubMed ID: 15564221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scientific analysis of second-hand smoke by the tobacco industry, 1929-1972.
    Schick S; Glantz S
    Nicotine Tob Res; 2005 Aug; 7(4):591-612. PubMed ID: 16085530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implications of the tobacco industry documents for public health and policy.
    Bero L
    Annu Rev Public Health; 2003; 24():267-88. PubMed ID: 12415145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tobacco industry successfully prevented tobacco control legislation in Argentina.
    Sebrié EM; Barnoya J; Pérez-Stable EJ; Glantz SA
    Tob Control; 2005 Oct; 14(5):e2. PubMed ID: 16183967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attempts to undermine tobacco control: tobacco industry "youth smoking prevention" programs to undermine meaningful tobacco control in Latin America.
    Sebrié EM; Glantz SA
    Am J Public Health; 2007 Aug; 97(8):1357-67. PubMed ID: 17600260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Social responsibility argument for the tobacco industry in Brazil].
    Cavalcante T; Carvalho Ade M; Rangel EC
    Salud Publica Mex; 2006; 48 Suppl 1():S173-82. PubMed ID: 17684681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determining responsibility for smoking in society: accountability continuum for Jordanian college students and its implication on FCTC implementation.
    Madanat HN; Barnes MD; Cole EC; Njord R
    Int Q Community Health Educ; 2009-2010; 30(3):239-55. PubMed ID: 20860982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Philippine tobacco industry: "the strongest tobacco lobby in Asia".
    Alechnowicz K; Chapman S
    Tob Control; 2004 Dec; 13 Suppl 2(Suppl 2):ii71-8. PubMed ID: 15564224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Avoiding "truth": tobacco industry promotion of life skills training.
    Mandel LL; Bialous SA; Glantz SA
    J Adolesc Health; 2006 Dec; 39(6):868-79. PubMed ID: 17116518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of corporate credibility in legitimizing disease promotion.
    McDaniel PA; Malone RE
    Am J Public Health; 2009 Mar; 99(3):452-61. PubMed ID: 19106419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current tobacco control policy trends in the United States.
    Stoner WI; Foley BX
    Clin Occup Environ Med; 2006; 5(1):85-99, ix. PubMed ID: 16446256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fiscal versus social responsibility: how Philip Morris shaped the public funds divestment debate.
    Wander N; Malone RE
    Tob Control; 2006 Jun; 15(3):231-41. PubMed ID: 16728755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mixed messages on tobacco: comparative exposure to public health, tobacco company- and pharmaceutical company-sponsored tobacco-related television campaigns in the United States, 1999-2003.
    Wakefield M; Szczypka G; Terry-McElrath Y; Emery S; Flay B; Chaloupka F; Saffer H
    Addiction; 2005 Dec; 100(12):1875-83. PubMed ID: 16367989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.